Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paik Ling Chuah, Nurnina Fareeha Jamal, Chai Jin Siew, Ros Suzanna Ahmad Bustamam, Vaishnavi Jeyasingam & Khei Choong Khong. (2021) Assessment of Adherence to Imatinib and Health-Related Quality of Life Among Patients with Gastrointestinal Stromal Tumor: A Cross-Sectional Study in an Oncology Clinic in Malaysia. Patient Preference and Adherence 15, pages 2175-2184.
Read now
Read now
Bee Kim Tan, Ping Chong Bee, Siew Siang Chua & Li-Chia Chen. (2021) Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review. Patient Preference and Adherence 15, pages 2563-2575.
Read now
Read now
Christel C. L. M. Boons, Vashti N. M. F. Tromp, Nienke J. M. Neppelenbroek, Lonneke Timmers, Natasja M. van Schoor, Eleonora L. Swart, N. Harry Hendrikse, Jeroen J. W. M. Janssen & Jacqueline G. Hugtenburg. (2019) Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients. Acta Oncologica 58:6, pages 891-896.
Read now
Read now
Articles from other publishers (8)
Catriona Parker, Danielle Berkovic, Darshini Ayton, Ella Zomer, Danny Liew & Andrew Wei. (2022) Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review. Current Oncology 29:6, pages 3807-3824.
Crossref
Crossref
Bee Kim Tan, Siew Siang Chua, Li-Chia Chen, Kian Meng Chang, Sharmini Balashanker & Ping Chong Bee. (2020) Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia. Journal of Oncology Pharmacy Practice 27:7, pages 1644-1656.
Crossref
Crossref
P. M. Lee, C. T. Chang & Z. M. Yusoff. (2020) Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital. International Journal of Clinical Pharmacy 43:1, pages 46-54.
Crossref
Crossref
Christel C. L. M. Boons, Yvonne M. Hartog, Jeroen J. W. M. Janssen, Anthe S. Zandvliet, René M. Vos, Eleonora L. Swart, N. Harry Hendrikse & Jacqueline G. Hugtenburg. (2020) Food‐effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden. European Journal of Haematology 105:2, pages 148-155.
Crossref
Crossref
Bee Kim Tan, Siew Siang Chua, Li-Chia Chen, Kian Meng Chang, Sharmini Balashanker & Ping Chong Bee. (2019) Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial. Supportive Care in Cancer 28:7, pages 3237-3247.
Crossref
Crossref
Ann Hewison, Karl Atkin, Dorothy McCaughan, Eve Roman, Alex Smith, Graeme Smith & Debra Howell. (2020) Experiences of living with chronic myeloid leukaemia and adhering to tyrosine kinase inhibitors: A thematic synthesis of qualitative studies. European Journal of Oncology Nursing 45, pages 101730.
Crossref
Crossref
Nirmala Bhoo-Pathy, Chiu-Wan Ng, Gerard Chin-Chye Lim, Nor Saleha Ibrahim Tamin, Richard Sullivan, Nanthini Thevi Bhoo-Pathy, Matin Mellor Abdullah, Merel Kimman, Shridevi Subramaniam, Marniza Saad, Nur Aishah Taib, Kian-Meng Chang, Pik-Pin Goh & Cheng-Har Yip. (2019) Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action. Journal of Oncology Practice 15:6, pages e537-e546.
Crossref
Crossref
Christel C. L. M. Boons, Lorette Harbers, Lonneke Timmers, Jan de Jong, Eleonora L. Swart, N. Harry Hendrikse, Jeroen J. W. M. Janssen & Jacqueline G. Hugtenburg. (2018) Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines. European Journal of Haematology 101:5, pages 643-653.
Crossref
Crossref